A

Asymchem Laboratories Tianjin Co Ltd
SZSE:002821

Watchlist Manager
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
Watchlist
Price: 77.04 CNY -0.81% Market Closed
Market Cap: 28.3B CNY
Have any thoughts about
Asymchem Laboratories Tianjin Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Asymchem Laboratories Tianjin Co Ltd

Current Assets 10.6B
Cash & Short-Term Investments 7.7B
Receivables 1.8B
Other Current Assets 1.2B
Non-Current Assets 8.2B
Long-Term Investments 1.2B
PP&E 6.1B
Intangibles 603.3m
Other Non-Current Assets 369.8m
Current Liabilities 1.9B
Accounts Payable 388.3m
Accrued Liabilities 190m
Short-Term Debt 74.9m
Other Current Liabilities 1.2B
Non-Current Liabilities 535.9m
Long-Term Debt 132.5m
Other Non-Current Liabilities 403.4m

Balance Sheet
Asymchem Laboratories Tianjin Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
144
265
1 084
828
605
414
2 122
6 232
4 418
4 772
Cash
0
0
0
0
0
0
0
6 232
4 418
0
Cash Equivalents
144
265
1 084
828
605
414
2 122
0
0
4 772
Short-Term Investments
0
29
0
0
37
0
0
401
3 005
4 235
Total Receivables
246
222
327
497
569
722
1 110
2 052
2 781
2 299
Accounts Receivables
237
212
295
451
525
659
986
1 817
2 515
2 080
Other Receivables
8
10
32
46
43
64
124
236
266
219
Inventory
117
129
219
260
424
449
726
1 396
1 510
945
Other Current Assets
7
21
16
30
60
54
72
229
146
101
Total Current Assets
514
666
1 645
1 615
1 694
1 639
4 030
10 310
11 860
12 352
PP&E Net
480
532
724
921
1 311
1 674
2 360
3 697
5 056
5 601
PP&E Gross
480
532
724
921
1 311
1 674
2 360
3 697
5 056
5 601
Accumulated Depreciation
186
237
295
356
451
532
673
882
1 164
1 538
Intangible Assets
54
65
64
67
118
122
286
374
473
466
Goodwill
0
0
0
0
0
0
43
146
146
146
Long-Term Investments
0
0
0
0
0
222
305
396
390
867
Other Long-Term Assets
10
8
12
35
63
103
135
233
313
336
Other Assets
0
0
0
0
0
0
43
146
146
146
Total Assets
1 058
N/A
1 272
+20%
2 445
+92%
2 637
+8%
3 185
+21%
3 759
+18%
7 158
+90%
15 156
+112%
18 239
+20%
19 767
+8%
Liabilities
Accounts Payable
65
109
139
153
276
267
522
552
569
454
Accrued Liabilities
20
36
54
29
63
75
111
214
369
307
Short-Term Debt
50
80
187
2
5
1
12
415
58
74
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
13
28
29
Other Current Liabilities
31
12
123
190
195
161
279
1 011
1 153
938
Total Current Liabilities
166
237
504
374
540
504
925
2 205
2 177
1 801
Long-Term Debt
20
0
0
0
0
0
0
46
110
106
Deferred Income Tax
0
2
3
5
25
61
87
117
89
117
Minority Interest
40
56
79
97
0
0
0
0
48
30
Other Liabilities
88
96
105
103
111
148
151
179
168
233
Total Liabilities
313
N/A
390
+25%
691
+77%
580
-16%
675
+16%
713
+6%
1 163
+63%
2 546
+119%
2 592
+2%
2 287
-12%
Equity
Common Stock
90
90
113
230
231
231
243
263
370
369
Retained Earnings
300
433
655
939
1 287
1 748
2 355
3 274
6 364
7 969
Additional Paid In Capital
357
357
981
1 039
1 105
1 146
3 539
9 564
10 144
9 612
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
152
117
88
137
482
1 247
494
Other Equity
1
1
5
1
6
8
4
9
17
22
Total Equity
746
N/A
881
+18%
1 754
+99%
2 058
+17%
2 511
+22%
3 046
+21%
5 995
+97%
12 610
+110%
15 647
+24%
17 480
+12%
Total Liabilities & Equity
1 058
N/A
1 272
+20%
2 445
+92%
2 637
+8%
3 185
+21%
3 759
+18%
7 158
+90%
15 156
+112%
18 239
+20%
19 767
+8%
Shares Outstanding
Common Shares Outstanding
180
180
226
230
231
231
243
366
363
363

See Also

Discover More